IFFIm disbursements support the pentavalent vaccine
- Impact
- IFFIm disbursements support the pentavalent vaccine
IFFIm disbursements support the pentavalent vaccine
IFFIm has provided Gavi with more than US$ 1 billion toward the purchase of pentavalent vaccine.
How the ‘walkers’ of the Haitian mountains deliver vaccines, with the help of IFFIm
Consider the blue propane tank that ensures Taillefer’s vaccines are refrigerated. The tank weighs 9 kg (20 lbs), and it is carried by Joseph Mesura atop his head each week to the teeming Port-au- Prince neighborhood of Carrefour, 16 km away.
Mesura is 65 years old. He balances the tank as he walks from Taillefer to Carrefour and back, up and down mountains, through fields and across the Rivière Froide. What road exists is rocky and full of holes, impassable in a light rain. That’s day one: a 6-hour round trip, without water or food, he says. On day two, Mesura makes the same journey again in order to collect the vaccines, passing small farms growing rice, sweet potato, cassava and yam on land that has been deforested. He has been doing this since 1988. On occasion, his two teenage sons lend a hand.
“When you don’t have money, it’s not hard to walk,” Mesura says. “The vaccines help the people. I am proud to help the community. It is a mission of God.” His coworker, Albert Hippolite, helped construct the clinic, called the Community Centre of Taillefer, in 1987. It and the vaccines that the clinic provides have transformed the health of the community. “I was born here [in 1947]. Before the building, members of my family all died — my brother, my cousins, my friend — because of a lack of healthcare,” he says. “Now, people don’t die of disease.”
Healthcare, nutrition and water hard to get in rural Haiti
The work of Mesura, Hippolite and others is how children in Taillefer are protected against disease, as with the pentavalent vaccine, the five-in-one shot rolled out nationally in Haiti in 2012 through support of the Vaccine Alliance, which has received US$ 1.3 billion for pentavalent from IFFIm (as of June 2015). Pentavalent was chosen first by the Haitian Ministry of Health among Gavi vaccines because of the high incidence of influenza among Haiti’s children.
Pentavalent protects children against the virus that causes it, haemophilus influenzae type B (Hib, which causes meningitis and pneumonia), as well as against diphtheria, tetanus, pertussis (whooping cough) and hepatitis B. Pentavalent is one of the vaccines being administered on this Monday at Taillefer’s satellite clinic in Mataillefer, several kilometres deeper in the mountains, to a group of about 20 women and children. As with the women in Taillefer, many have walked all night from a more distant village to receive them.
Those in attendance say they make the journey because their villages have no running water, no health centre, no school and no jobs. Professional healthcare is a rare opportunity. UNICEF — a Gavi partner — has spread word through village churches of a campaign against maternal and neonatal tetanus (MNT), says Christophe Boulierac, Communication Chief for UNICEF-Haiti.
The UNICEF campaign lends an opportunity to continue routine immunisation with pentavalent, as well as vaccines against measles, rubella, polio, tuberculosis and — soon with Gavi support — rotavirus, after the Ministry of Health implements its plan to increase cold chain capacity. IFFIm this year began funding Gavi’s rotavirus vaccine programme.
Chief Gigi maintains her post
The manager of the Taillefer clinic, Ghislaine Alphonse — affectionately called Chief Gigi — lives at the facility during the work week. It includes an examination room and a supply area.
“The people understand the importance of vaccines,” she says. “They come from all over the Malanga area, sometimes 10 hours on foot. They left at midnight or 1 a.m. to come here for the vaccine today.” A handful of men milling about are “walkers.” Their job is to accompany the women on their overnight journey to Taillefer, as none of the women’s husbands joined them.
The lack of funding and capacity has affected the introduction of vaccines, says Jeannot Francois, Extended Programme for Immunisation (EPI) manager for Haiti’s Ministry of Health. Haiti must wait until 2014 to roll out pneumococcal vaccine — with support of Gavi, which has received US$ 90.7 million from IFFIm for the vaccine — for the simple reason that there is not enough cold storage capacity.
But thanks to IFFIm, Gavi and its Vaccine Alliance partners, the children of Taillefer now have pentavalent and soon will have rotavirus and pneumococcal vaccines. “Ça va,” says Chief Gigi, who has worked at the clinic for 22 years. “We will do new campaigns.”
Keeping kids healthy and alive is not so easy in the tiny Haitian mountain village of Taillefer. Photo credit: Gavi/2013/Evelyn Hockstein.
Restricted Access Library
The material in this Restricted Access Library is intended to be accessed only by persons with residence within the territory of a Member State of the European Union and is not intended to be viewed by any other persons. The material in this Restricted Access Library is provided by IFFIm for information purposes only and the materials contained herein were accurate only as of their respective dates. Certain information in the materials contained herein is not intended to be, and is not, current. IFFIm accepts no obligation to update any material contained herein.
Persons with residence outside the territory of a Member State of the European Union who have access to or consult any materials posted in this Restricted Access Library should refrain from any action in respect of the securities referred to in such materials and are otherwise required to comply with all applicable laws and regulations in their country of residence.
By clicking Access restricted content: DYNAMIC-LINK-TEXT I confirm that I have read and understood the foregoing and agree that I will be bound by the restrictions and conditions set forth on this page.
The materials in this Restricted Access Library are for distribution only to persons who are not a "retail client" within the meaning of section 761G of the Corporations Act 2001 of Australia and are also sophisticated investors, professional investors or other investors in respect of whom disclosure is not required under Part 6D.2 of the Corporations Act 2001 of Australia and, in all cases, in such circumstances as may be permitted by applicable law in any jurisdiction in which an investor may be located.
The materials in this Restricted Access Library and any documents linked from it are not for access or distribution in any jurisdiction where such access or distribution would be illegal. All of the securities referred to in this Restricted Access Library and in the linked documents have been sold and delivered. The information contained herein and therein does not constitute an offer for sale in the United States or in any other country. The securities described herein and therein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable state securities laws.
Each person accessing the Restricted Access Library confirms that they are a person who is entitled to do so under all applicable laws, regulations and directives in all applicable jurisdictions. Neither IFFIm nor any of their directors, employees, agents or advisers accepts any liability whatsoever for any loss (including, without limitation, any liability arising from any fault or negligence on the part of IFFIm or its respective directors, employees, agents or advisers) arising from access to Restricted Access Library by any person not entitled to do so.